• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    73.44 Up 1.23(1.70%) Mar 27, 4:00PM EDT
    |After Hours : 73.44 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue -   -   -   13,625  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   13,625  
    Operating Expenses
    Research Development50,149  34,965  28,440  24,151  
    Selling General and Administrative3,741  6,155  6,126  6,142  
    Non Recurring -   -  400  8,406  
    Others -   -   -  3,409  
    Total Operating Expenses -   -   -  42,108  
    Operating Income or Loss (53,890) (41,120) (34,966) (28,483)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,406  1,770  270  (106)
    Earnings Before Interest And Taxes(52,484)(39,350)(34,696)(28,589)
    Interest Expense2,604   -   -   -  
    Income Before Tax(55,088)(39,350)(34,696)(28,589)
    Income Tax Expense(181)292  68  2,129  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(54,907)(39,642)(34,764)(30,718)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (54,907) (39,642) (34,764) (30,718)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (54,907) (39,642) (34,764) (30,718)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.